Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Montana.
Press releases published on July 4, 2025
Cherry Servers CEO Identifies Five Warning Signs of Excessive Cloud Spend Amid Growing Industry Shift
GlobeNewswire
·
July 4, 2025
Vilnius, Lithuania, July 04, 2025 (GLOBE NEWSWIRE) -- As more businesses evaluate the long-term financial impact of cloud adoption, Vaidas Rutkauskas, the CEO of cloud infrastructure provider Cherry Servers, is raising awareness around five key indicators …
Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions
GlobeNewswire
·
July 4, 2025
Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions Distinguished experts Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence Steinman have joined Immuthera’s Scientific Advisory …
CertiK 行政總裁在香港交流策略後鞏固機構市場地位
GlobeNewswire
·
July 4, 2025
香港, July 04, 2025 (GLOBE NEWSWIRE) -- 規模最大的 Web3安全服務供應商 CertiK 正式推出CertiK Institutional，這套全週期諮詢與安全解決方案專為全球監管機構、金融機構、銀行、資產管理公司、企業及數碼資產平台打造，進一步強化了該公司在機構領域的市場根基。 是次宣佈為公司聯合創辦人暨行政總裁 Ronghui Gu 教授在香港主持的兩日高級會議及圓桌論壇完美作結。 這些交流合作進一步強化了 CertiK 與受監管金融業及主管機關的合作關係。 …
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
GlobeNewswire
·
July 4, 2025
Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone payments from Centessa Pharmaceuticals pursuant to its research collaboration with …
AB Science : Le masitinib reçoit l'autorisation de la FDA et de l'EMA pour l’etude confirmatoire de phase 3 dans le cancer de la prostate métastatique hormono-resistant
GlobeNewswire
·
July 4, 2025
COMMUNIQUÉ DE PRESSE LE MASITINIB REÇOIT L'AUTORISATION DE LA FDA ET DE L'EMA POUR L’ETUDE CONFIRMATOIRE DE PHASE 3 DANS LE CANCER DE LA PROSTATE MÉTASTATIQUE HORMONO-RESISTANT, AVEC UNE SÉLECTION DES PATIENTS BASÉE SUR DES BIOMARQUEURS CIBLANT LA …
AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer
GlobeNewswire
·
July 4, 2025
PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN PATIENT SELECTION TARGETING POPULATION MOST LIKELY TO BENEFIT Paris, July 4, 2025, 8am CET AB …
Strüngmann Award zeichnet Gründerteam von Araris Biotech als Preisträger 2025 aus
GlobeNewswire
·
July 4, 2025
Die Expertenjury wählte Dr. Dragan Grabulovski, Dr. Philipp Spycher und Dr. Isabella Attinger-Toller von Araris Biotech, aus einer Gruppe herausragender Life-Science-Unternehmer aus Das Gründerteam von Araris Biotech entwickelt eine bahnbrechende …
Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner
GlobeNewswire
·
July 4, 2025
The expert jury selected Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D. of Araris Biotech, from a group of outstanding life science entrepreneurs The founding team is developing a breakthrough technology to establish …
Aduro Clean Technologies gibt Gewährung von Aktienoptionen und RSUs bekannt
GlobeNewswire
·
July 4, 2025
LONDON, Ontario, July 04, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro” oder das „Unternehmen”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen im Bereich sauberer Technologien, das die Kraft der Chemie nutzt, um minderwertige …
Aduro Clean Technologies annonce l’octroi d’options sur actions et d’unités d’actions restreintes
GlobeNewswire
·
July 4, 2025
LONDON, Ontario, 04 juill. 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (« Aduro » ou la « Société ») (Nasdaq : ADUR) (CSE : ACT) (FSE : 9D5), une société technologique propre qui recycle chimiquement les matières premières de faible valeur comme …
BTC Miner Users Tap to Earn as Bitcoin Surges to $110K — Investors Make Gains from the Couch
GlobeNewswire
·
July 4, 2025
San Francisco, CA, July 03, 2025 (GLOBE NEWSWIRE) -- Bitcoin has once again asserted its dominance in the digital asset space, recently breaking through the $110,149.8 mark and signaling renewed investor confidence in its long-term value. As Ethereum (ETH …
Starlight Retail Joins Google Cloud Partner Advantage Program to Deliver Advanced Cloud and AI Solutions in Pakistan
GlobeNewswire
·
July 4, 2025
LAHORE, Pakistan, July 03, 2025 (GLOBE NEWSWIRE) -- Starlight Retail, a global technology solutions provider, announced today that it has joined the Google Cloud Partner Advantage program as a Partner level partner for the Service engagement model. This …
Why High-Net-Worth Investors Are Turning to BTC Miner for Daily Crypto Returns Amid Market Turbulence
GlobeNewswire
·
July 4, 2025
Chicago, Illinois, July 03, 2025 (GLOBE NEWSWIRE) -- Introducing BTC Miner — the cloud mining solution designed not for traders, but for wealth builders. For family offices, crypto funds, and large-scale investors seeking dependable yield in a volatile …